You are here

bloodthinners

Doctors reserve judgement on new blood clot drugs

Reuters

Tue, 11/15/11 - 12:36 pm

Boehringer Ingelheim

Bristol-Myers Squibb

J&J-Bayer Blood Thinner May Enter $1B Market

Bloomberg

Mon, 11/14/11 - 10:46 am

Bayer Shares Rise 4% After Xarelto Wins U.S. FDA Approval

Bloomberg

Mon, 11/7/11 - 09:24 am

Pradaxa hit with pre-treatment screening advice

Fierce Pharma

Fri, 10/28/11 - 11:21 am

Boehringer Ingelheim

Study: Pradaxa use results in higher per-patient costs

Fierce Pharma

Thu, 10/20/11 - 12:49 pm

Boehringer Ingelheim

Bayer’s Xarelto Wins EU Drug Panel Backing for Added Use

Bloomberg

Fri, 09/23/11 - 08:55 am

Momenta Hit on Approval of Blood Thinner Rival

TheStreet.com

Mon, 09/19/11 - 12:09 pm

Even if FDA approves Xarelto, Pradaxa could still gain

Fierce Pharma

Mon, 09/12/11 - 10:39 am

Boehringer Ingelheim

Citi analyst expects FDA approval of J&J anticlotting drug after committee recommendatio

Yahoo/AP

Fri, 09/9/11 - 11:23 am

J&J: FDA Panel Recommends New Approved Use for Xarelto

Barron's

Fri, 09/9/11 - 10:16 am

advisory panels

Bayer Is ‘Still Confident’ in Xarelto Trial After FDA Comments

Bloomberg

Tue, 09/6/11 - 12:14 pm

Next Week Could Be Big for Johnson & Johnson: Analyst

Barron's

Fri, 09/2/11 - 12:13 pm

Analyst Says Xarelto Niche "Still Secure"

Forbes

Mon, 08/29/11 - 10:57 am

Bristol-Myers Squibb

Pfizer, Bristol-Myers May Lead $9B Stroke Market

Bloomberg

Mon, 08/29/11 - 10:56 am

Bristol-Myers Squibb

Pfizer & Bristol-Myers to Release Highly Anticipated Data on Bloodthinner Hopeful

Motley Fool

Wed, 08/24/11 - 10:19 am

Bristol-Myers Squibb

Data may prove Bristol, Pfizer drug a winner

Yahoo/Reuters

Mon, 08/22/11 - 11:40 am

Bristol-Myers Squibb

Pages